Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application
Open Access
- 31 July 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 1615
- https://doi.org/10.3389/fimmu.2020.01615
Abstract
The liver exhibits intrinsic immune regulatory properties that maintain tolerance to endogenous and exogenous antigens, and provide protection against pathogens. Such an immune privilege contributes to susceptibility to spontaneous acceptance despite major histocompatibility complex mismatch when transplanted in animal models. Furthermore, the presence of a liver allograft can suppress the rejection of other solid tissue/organ grafts from the same donor. Despite this immune privilege of the livers, to control the undesired alloimmune responses in humans, most liver transplant recipients require long-term treatment with immune-suppressive drugs that predispose to cardiometabolic side effects and renal insufficiency. Understanding the mechanism of liver transplant tolerance and crosstalk between a variety of hepatic immune cells, such as dendritic cells, Kupffer cells, liver sinusoidas endothelial cells, hepatic stellate cells and so on, and alloreactive T cells would lead to the development of strategies for deliberate induction of more specific immune tolerance in a clinical setting. In this review article, we focus on results derived from basic studies that have attempted to elucidate the immune modulatory mechanisms of liver constituent cells and clinical trials that induced immune tolerance after liver transplantation by utilizing the immune-privilege potential of the liver.This publication has 147 references indexed in Scilit:
- Interferon-γTriggers Hepatic Stellate Cell-Mediated Immune Regulation through MEK/ERK Signaling PathwayJournal of Immunology Research, 2013
- Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantationJCI Insight, 2012
- Structure and function of immunoglobulinsJournal of Allergy and Clinical Immunology, 2010
- PD‐1/B7‐H1 Interaction Contribute to the Spontaneous Acceptance of Mouse Liver AllograftAmerican Journal of Transplantation, 2009
- Pivotal Role of mTOR Signaling in Hepatocellular CarcinomaGastroenterology, 2008
- Allospecific CD154+ T Cells Associate with Rejection Risk After Pediatric Liver TransplantationAmerican Journal of Transplantation, 2008
- Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipientsJCI Insight, 2008
- Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificitiesBlood, 2007
- A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipientsGut, 2007
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005